AU2001244634A1 - Diazepane derivatives or salts thereof - Google Patents
Diazepane derivatives or salts thereofInfo
- Publication number
- AU2001244634A1 AU2001244634A1 AU2001244634A AU4463401A AU2001244634A1 AU 2001244634 A1 AU2001244634 A1 AU 2001244634A1 AU 2001244634 A AU2001244634 A AU 2001244634A AU 4463401 A AU4463401 A AU 4463401A AU 2001244634 A1 AU2001244634 A1 AU 2001244634A1
- Authority
- AU
- Australia
- Prior art keywords
- salts
- diazepane derivatives
- diazepane
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-096858 | 2000-03-31 | ||
| JP2000096858 | 2000-03-31 | ||
| PCT/JP2001/002673 WO2001074791A1 (en) | 2000-03-31 | 2001-03-29 | Diazepane derivatives or salts thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001244634A1 true AU2001244634A1 (en) | 2001-10-15 |
Family
ID=18611560
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU29827/01A Ceased AU776053B2 (en) | 2000-03-31 | 2001-03-22 | Diazepan derivatives or salts thereof |
| AU2001244634A Abandoned AU2001244634A1 (en) | 2000-03-31 | 2001-03-29 | Diazepane derivatives or salts thereof |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU29827/01A Ceased AU776053B2 (en) | 2000-03-31 | 2001-03-22 | Diazepan derivatives or salts thereof |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US6642224B1 (en) |
| EP (2) | EP1415990B1 (en) |
| JP (1) | JP3788349B2 (en) |
| KR (1) | KR100739359B1 (en) |
| CN (1) | CN1226292C (en) |
| AR (1) | AR027985A1 (en) |
| AT (2) | ATE340166T1 (en) |
| AU (2) | AU776053B2 (en) |
| BR (1) | BR0101264A (en) |
| CA (1) | CA2395846C (en) |
| DE (2) | DE60123294T2 (en) |
| DK (1) | DK1273575T3 (en) |
| ES (2) | ES2271464T3 (en) |
| HU (1) | HUP0101333A3 (en) |
| MX (1) | MXPA01003279A (en) |
| PL (1) | PL207651B1 (en) |
| PT (1) | PT1273575E (en) |
| RU (1) | RU2257381C2 (en) |
| TR (1) | TR200401955T4 (en) |
| TW (1) | TW575569B (en) |
| WO (1) | WO2001074791A1 (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001064642A2 (en) * | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
| AU776053B2 (en) | 2000-03-31 | 2004-08-26 | Astellas Pharma Inc. | Diazepan derivatives or salts thereof |
| ATE374765T1 (en) | 2000-07-27 | 2007-10-15 | Lilly Co Eli | SUBSTITUTED HETEROCYCLIC AMIDES |
| MXPA03003572A (en) * | 2000-11-22 | 2003-07-14 | Yamanouchi Pharma Co Ltd | Substituted benzene derivatives or salts thereof. |
| US7163938B2 (en) | 2000-11-28 | 2007-01-16 | Eli Lilly And Company | Substituted carboxamides |
| SE0102764D0 (en) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| WO2003050088A1 (en) * | 2001-12-07 | 2003-06-19 | Eli Lilly And Company | Substituted heterocyclic carboxamides with antithrombotic activity |
| TWI319387B (en) * | 2002-04-05 | 2010-01-11 | Astrazeneca Ab | Benzamide derivatives |
| MXPA05013536A (en) * | 2003-06-18 | 2006-03-09 | Merck Patent Gmbh | Pyrrolidin-1, 2- dicarboxylic acid- 1- [(4- ethinyl- phenyl) - amid]- 2- [(phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis. |
| EP1670783A2 (en) | 2003-09-30 | 2006-06-21 | Eli Lilly And Company | Antithrombotic aromatic ethers |
| US7700628B2 (en) | 2004-11-24 | 2010-04-20 | Eli Lilly And Company | Aromatic ether derivatives useful as thrombin inhibitors |
| ES2330461T3 (en) | 2004-11-29 | 2009-12-10 | Eli Lilly And Company | ANTHROMBOTIC DIAMIDS. |
| WO2006083003A1 (en) | 2005-02-02 | 2006-08-10 | Ajinomoto Co., Inc. | Novel benzamidine compound |
| GB0521244D0 (en) | 2005-10-19 | 2005-11-30 | Astrazeneca Ab | Benzamide compounds |
| TW200734304A (en) | 2005-11-08 | 2007-09-16 | Astellas Pharma Inc | Benzene derivative or salt thereof |
| CN101595092B (en) | 2006-11-02 | 2012-02-01 | 米伦纽姆医药公司 | Methods of synthesizing pharmaceutical salts of a factor XA inhibitor |
| JP2010120852A (en) * | 2007-03-09 | 2010-06-03 | Daiichi Sankyo Co Ltd | New diamide derivative |
| WO2010005087A1 (en) | 2008-07-11 | 2010-01-14 | 味の素株式会社 | Amidine derivative |
| TW201021832A (en) * | 2008-09-30 | 2010-06-16 | Astellas Pharma Inc | Pharmaceutical composition for oral administration |
| WO2012006477A1 (en) | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| WO2012006474A2 (en) | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| JP5823514B2 (en) | 2010-07-07 | 2015-11-25 | アーデリクス，インコーポレーテッド | Compounds and methods for inhibiting phosphate transport |
| WO2012006473A1 (en) | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| WO2012006475A1 (en) * | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| US20130261130A1 (en) * | 2010-11-01 | 2013-10-03 | Shaheen Ahmed | Neurotrypsin inhibitors |
| JPWO2013161871A1 (en) * | 2012-04-25 | 2015-12-24 | 興和株式会社 | Thiophene derivative having TLR inhibitory action |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5417200A (en) * | 1994-01-25 | 1995-05-23 | Wasielewski; John J. | Lantern cooker |
| AU688628B2 (en) | 1994-12-02 | 1998-03-12 | Yamanouchi Pharmaceutical Co., Ltd. | Novel amidinonaphthyl derivative or salt thereof |
| US6417200B1 (en) | 1997-06-26 | 2002-07-09 | Eli Lilly And Company | Antithrombotic agents |
| ATE306261T1 (en) | 1997-06-26 | 2005-10-15 | Lilly Co Eli | ANTITHROMBOTIC AGENTS |
| IL133621A0 (en) | 1997-06-26 | 2001-04-30 | Lilly Co Eli | Antithrombotic agents |
| AU8270298A (en) | 1997-06-26 | 1999-01-19 | Eli Lilly And Company | Antithrombotic agents |
| US6140351A (en) | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
| ATE260103T1 (en) | 1997-12-19 | 2004-03-15 | Schering Ag | ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTICOAGULANTS |
| AU2074699A (en) * | 1998-01-26 | 1999-08-09 | Yamanouchi Pharmaceutical Co., Ltd. | Novel benzene-fused heterocyclic derivatives or salts thereof |
| JP2002533454A (en) | 1998-12-23 | 2002-10-08 | イーライ・リリー・アンド・カンパニー | Aromatic amides |
| JP2002533453A (en) | 1998-12-23 | 2002-10-08 | イーライ・リリー・アンド・カンパニー | Heteroaromatic amides as inhibitors of factor Xa |
| AU2054700A (en) | 1998-12-23 | 2000-07-31 | Eli Lilly And Company | Antithrombotic amides |
| JP4390024B2 (en) * | 1999-04-23 | 2009-12-24 | アステラス製薬株式会社 | Novel diazepane derivatives or salts thereof |
| CA2385592C (en) | 1999-09-17 | 2011-01-11 | Bing-Yan Zhu | Benzamides and related inhibitors of factor xa |
| US6632815B2 (en) | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| BR0014078A (en) | 1999-09-17 | 2002-12-31 | Millennium Pharm Inc | Xa factor inhibitors |
| WO2001064642A2 (en) | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
| AU776053B2 (en) * | 2000-03-31 | 2004-08-26 | Astellas Pharma Inc. | Diazepan derivatives or salts thereof |
| ATE374765T1 (en) * | 2000-07-27 | 2007-10-15 | Lilly Co Eli | SUBSTITUTED HETEROCYCLIC AMIDES |
| US7163938B2 (en) * | 2000-11-28 | 2007-01-16 | Eli Lilly And Company | Substituted carboxamides |
-
2001
- 2001-03-22 AU AU29827/01A patent/AU776053B2/en not_active Ceased
- 2001-03-28 PL PL346731A patent/PL207651B1/en not_active IP Right Cessation
- 2001-03-29 JP JP2001572486A patent/JP3788349B2/en not_active Expired - Fee Related
- 2001-03-29 AU AU2001244634A patent/AU2001244634A1/en not_active Abandoned
- 2001-03-29 WO PCT/JP2001/002673 patent/WO2001074791A1/en active IP Right Grant
- 2001-03-29 DE DE60123294T patent/DE60123294T2/en not_active Expired - Lifetime
- 2001-03-29 MX MXPA01003279A patent/MXPA01003279A/en active IP Right Grant
- 2001-03-29 TR TR2004/01955T patent/TR200401955T4/en unknown
- 2001-03-29 AT AT03029061T patent/ATE340166T1/en not_active IP Right Cessation
- 2001-03-29 CA CA002395846A patent/CA2395846C/en not_active Expired - Fee Related
- 2001-03-29 ES ES03029061T patent/ES2271464T3/en not_active Expired - Lifetime
- 2001-03-29 ES ES01917634T patent/ES2217129T3/en not_active Expired - Lifetime
- 2001-03-29 RU RU2001108494/04A patent/RU2257381C2/en not_active IP Right Cessation
- 2001-03-29 US US10/148,544 patent/US6642224B1/en not_active Expired - Fee Related
- 2001-03-29 DK DK01917634T patent/DK1273575T3/en active
- 2001-03-29 PT PT01917634T patent/PT1273575E/en unknown
- 2001-03-29 EP EP03029061A patent/EP1415990B1/en not_active Expired - Lifetime
- 2001-03-29 AT AT01917634T patent/ATE267178T1/en active
- 2001-03-29 DE DE60103390T patent/DE60103390T2/en not_active Expired - Lifetime
- 2001-03-29 EP EP01917634A patent/EP1273575B1/en not_active Expired - Lifetime
- 2001-03-29 AR ARP010101497A patent/AR027985A1/en active IP Right Grant
- 2001-03-30 TW TW90107761A patent/TW575569B/en not_active IP Right Cessation
- 2001-03-30 KR KR1020010016952A patent/KR100739359B1/en not_active IP Right Cessation
- 2001-03-30 CN CNB011121904A patent/CN1226292C/en not_active Expired - Fee Related
- 2001-03-30 BR BR0101264-9A patent/BR0101264A/en not_active IP Right Cessation
- 2001-03-30 HU HU0101333A patent/HUP0101333A3/en unknown
-
2003
- 2003-09-08 US US10/656,129 patent/US7307074B2/en not_active Ceased
-
2008
- 2008-09-03 US US12/203,640 patent/USRE43481E1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001244634A1 (en) | Diazepane derivatives or salts thereof | |
| AU2001280099A1 (en) | 4-acylaminopyrazole derivatives | |
| AU2001230584A1 (en) | 1h-imidazopyridine derivatives | |
| AU2002221047A1 (en) | Quinazolinone derivatives | |
| AU2002224064A1 (en) | Substituted benzene derivatives or salts thereof | |
| AU2001230537A1 (en) | Pyridoxazine derivatives | |
| AU2001262150A1 (en) | 2-(nitrogen-heterocyclic)pyrimidone derivatives | |
| AU2001281802A1 (en) | 6-phenylpyrrolopyrimidinedione derivatives | |
| AU2001278790A1 (en) | 1h-imidazopyridine derivatives | |
| AU2001248748A1 (en) | Substituted piperazine compounds | |
| AU2002234010A1 (en) | Benzamidine derivatives | |
| AU2002213978A1 (en) | Substituted C-cyclohexylmethylamine derivatives | |
| AU2001252247A1 (en) | Isothiazole derivatives | |
| IL155103A0 (en) | Substituted c-cyclohexylmethylamine derivatives | |
| AU2002212301A1 (en) | Diazacycloalkanedione derivatives | |
| AU2001267852A1 (en) | Novel pyrazinone derivatives | |
| AU2002212959A1 (en) | Cycloalkylfluorosulfonamide derivatives | |
| AU2001238590A1 (en) | Substituted piperazine compounds | |
| AU2001289937A1 (en) | Substituted 1-aminobutan-3-ol derivatives | |
| AU2002215212A1 (en) | 1-methylcarbapenem derivatives | |
| AU2001258841A1 (en) | Heterocyclic compounds | |
| IL155106A0 (en) | Substituted 1-aminobutan-3-ol derivatives | |
| IL150557A0 (en) | Substituted aminomethyl-phenyl-cyclohexane derivatives | |
| AU2001230565A1 (en) | Perfluoroisopropylbenzene derivatives | |
| AU2001254661A1 (en) | Aminosulfonylbiphenyl derivatives |